Physician

Corey Scott Frucht, M.D., PH.D.

According to 2025 Medicare claims, Corey Frucht, M.D., PH.D. (NPI: 1457606238) practices dermatology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is J ROBERT WEST, M.D., INC (NPI: 1932154788; TIN: 953134847) and primary practice location at 93105-5313.

Frucht's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,750 traditional Medicare patients, billed 16,807 HCPCS/CPT codes, and received $662,885 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 899 prescription claims across 410 beneficiaries totaling $346,539 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 53 records totaling $984. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $47,382 to $662,885. Similarly, Part D prescription costs have risen steadily, from $3,840 to $346,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	170	905	$47,382
2017	574	3,949	$211,113
2018	774	5,547	$298,239
2019	973	7,823	$358,866
2020	822	6,505	$311,451
2021	1,069	8,671	$436,010
2022	1,410	11,146	$564,993
2023	1,576	13,890	$639,406
2024	1,750	16,807	$662,885

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	49	85	$3,840
2017	143	279	$48,736
2018	214	415	$116,648
2019	274	570	$188,335
2020	238	496	$157,562
2021	278	595	$248,065
2022	330	693	$163,232
2023	369	864	$360,755
2024	410	899	$346,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	271	271	$76
11102	Biopsy of related skin growth, first growth	837	1,039	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,415	2,692	$65
17000	Destruction of precancer skin growth, 1 growth	1,111	1,677	$39
17003	Destruction of precancer skin growth, 2-14 growths	935	7,224	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	31	980	$139,934
Taltz Autoinjector	Ixekizumab	11	364	$85,992
Otezla	Apremilast	15	450	$72,403
Clobetasol Propionate	Clobetasol Propionate	107	3,503	$6,263
Betamethasone Dipropionate	Betamethasone Dipropionate	85	2,595	$4,485

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$984	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Corey Scott Frucht, M.D., PH.D.?

Tedicare shows public-source Medicare data for Corey Scott Frucht, M.D., PH.D. (NPI 1457606238), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Corey Scott Frucht, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Corey Scott Frucht, M.D., PH.D.?

Corey Scott Frucht, M.D., PH.D. is linked to J ROBERT WEST, M.D., INC (billing NPI 1932154788) in the available physician profile data.

Does Corey Scott Frucht, M.D., PH.D. have Open Payments data?

Corey Scott Frucht, M.D., PH.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.